139 related articles for article (PubMed ID: 18442082)
1. Ab initio computational study of positron emission tomography ligands interacting with lipid molecule for the prediction of nonspecific binding.
Rosso L; Gee AD; Gould IR
J Comput Chem; 2008 Nov; 29(14):2397-405. PubMed ID: 18442082
[TBL] [Abstract][Full Text] [Related]
2. Further evaluation of quantum chemical methods for the prediction of non-specific binding of positron emission tomography tracers.
Dickson CJ; Gee AD; Bennacef I; Gould IR; Rosso L
Phys Chem Chem Phys; 2011 Dec; 13(48):21552-7. PubMed ID: 22052158
[TBL] [Abstract][Full Text] [Related]
3. Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
Fukuzawa K; Kitaura K; Uebayasi M; Nakata K; Kaminuma T; Nakano T
J Comput Chem; 2005 Jan; 26(1):1-10. PubMed ID: 15521089
[TBL] [Abstract][Full Text] [Related]
4. Concept of reaction volume in the in vivo ligand-receptor model.
Delforge J; Syrota A; Bendriem B
J Nucl Med; 1996 Jan; 37(1):118-25. PubMed ID: 8543980
[TBL] [Abstract][Full Text] [Related]
5. Fractionation of peptide with disulfide bond for quantum mechanical calculation of interaction energy with molecules.
Chen XH; Zhang DW; Zhang JZ
J Chem Phys; 2004 Jan; 120(2):839-44. PubMed ID: 15267920
[TBL] [Abstract][Full Text] [Related]
6. Theoretical method for full ab initio calculation of DNA/RNA-ligand interaction energy.
Chen XH; Zhang JZ
J Chem Phys; 2004 Jun; 120(24):11386-91. PubMed ID: 15268172
[TBL] [Abstract][Full Text] [Related]
7. Quantum mechanical map for protein-ligand binding with application to beta-trypsin/benzamidine complex.
Zhang DW; Xiang Y; Gao AM; Zhang JZ
J Chem Phys; 2004 Jan; 120(3):1145-8. PubMed ID: 15268233
[TBL] [Abstract][Full Text] [Related]
8. [Strategy for development of imaging biomarkers].
Ishiwata K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.
Leopoldo M; Lacivita E; De Giorgio P; Contino M; Berardi F; Perrone R
Bioorg Med Chem; 2009 Jan; 17(2):758-66. PubMed ID: 19081257
[TBL] [Abstract][Full Text] [Related]
10. Models of molecular geometry.
Gillespie RJ; Robinson EA
Chem Soc Rev; 2005 May; 34(5):396-407. PubMed ID: 15852152
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 and radiopharmaceutical metabolism.
Giron MC; Portolan S; Bin A; Mazzi U; Cutler CS
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):254-66. PubMed ID: 18475251
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography compartmental models.
Gunn RN; Gunn SR; Cunningham VJ
J Cereb Blood Flow Metab; 2001 Jun; 21(6):635-52. PubMed ID: 11488533
[TBL] [Abstract][Full Text] [Related]
14. Identifying receptor-ligand interactions through an ab initio approach.
Salazar PF; Seminario JM
J Phys Chem B; 2008 Jan; 112(4):1290-2. PubMed ID: 18181603
[TBL] [Abstract][Full Text] [Related]
15. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
16. Decay data and production yields of some non-standard positron emitters used in PET.
Qaim SM
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):111-20. PubMed ID: 18174879
[TBL] [Abstract][Full Text] [Related]
17. In vitro receptor binding assays: general methods and considerations.
Bigott-Hennkens HM; Dannoon S; Lewis MR; Jurisson SS
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):245-53. PubMed ID: 18475249
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceuticals: molecular imaging using positron emission tomography.
Antoni G; Långström B
Handb Exp Pharmacol; 2008; (185 Pt 1):177-201. PubMed ID: 18626804
[TBL] [Abstract][Full Text] [Related]
19. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.
Najjar AM; Nishii R; Maxwell DS; Volgin A; Mukhopadhyay U; Bornmann WG; Tong W; Alauddin M; Gelovani JG
J Nucl Med; 2009 Mar; 50(3):409-16. PubMed ID: 19223410
[TBL] [Abstract][Full Text] [Related]
20. [The receptor binding study in vivo].
Inoue O; Kobayashi K
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):215-25. PubMed ID: 7975926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
